Skip to main content

Latest SEC Filings — Page 135

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Teamshares Adds 16M-Share Primary Offering to Prospectus Amid Going Concern
ProForm 424B3TMS · Form 424B3 · 2026-08-17
American Water-Essential Utilities Merger Clears HSR Antitrust Review
Form 425AWK · Form 425 · 2026-08-17
Evaxion Launches EVX-05 Glioblastoma Vaccine, Ends EVX-03
Form 6-KEVAX · Form 6-K · 2026-08-17
UNIFI Sells Non-Strategic Real Estate for $60M to Cut Debt
Form 8-KUFI · Form 8-K · 2026-08-17
Marvion Approves 1-for-100 Reverse Split, Name Change to United KSK, and New Incentive Plan
ProForm PRE 14CMVNC · Form PRE 14C · 2026-08-17
MINISO Pre-Announces H1 2026: Revenue Up 22-23%, But Adjusted Net Profit Declines 1-3%
ProForm 6-KMNSO · Form 6-K · 2026-08-17
Definitive Statement Lays Out $39.4M PIPE, Convertible Note Terms, and Board Overhaul
ProForm DEF 14CVIP · Form DEF 14C · 2026-08-17
NRx Pharmaceuticals Reports Q2 Results, FDA Ketamine Progress, and DARPA Selection
ProForm 8-KNRXP · Form 8-K · 2026-08-17
WhiteFiber to Acquire Two NC Data Center Sites for $60M, Adding 60 MW Initial Capacity
Form 8-KWYFI · Form 8-K · 2026-08-17
Bakkt Names Matt White CFO, Succeeding Karen Alexander
Form 8-KBKKT · Form 8-K · 2026-08-17
Inhibitor Therapeutics Seeks Approval for 20M Share Incentive Plan Amid Going Concern
ProForm DEF 14AINTI · Form DEF 14A · 2026-08-17
Steakholder Foods Registers Resale of 5.37M ADSs from July Private Placement
ProForm F-3STKH · Form F-3 · 2026-08-17
Radiopharm Secures FDA End-of-Phase 2 Meeting for RAD101, Phase 2b Shows 93% Concordance
ProForm 6-KRADX · Form 6-K · 2026-08-17
Nasdaq Moves to Delist Fast Track Group; Trading Suspension Set for August 18
ProForm 6-KFTRK · Form 6-K · 2026-08-17
HIVE Reports Q1 FY2027 Revenue of $79.1M, Contracted GPU Cloud ARR Reaches $110M
ProForm 8-KHIVE · Form 8-K · 2026-08-17
Brandywine Launches $100M Debt Tender Offer for 2028 and 2029 Notes
Form 8-KBDN · Form 8-K · 2026-08-17
Nuo Therapeutics Q2 Revenue Jumps 150% as Losses Narrow; Loan Amended
Form 8-KAURX · Form 8-K · 2026-08-17
DEFSEC Announces CAD$5.54M Private Placement with Warrants
ProForm 6-KDFSC · Form 6-K · 2026-08-17
L3Harris CEO Kubasik Out After Conduct Probe; Mehta Named Successor
ProForm 8-KLHX · Form 8-K · 2026-08-17
Prairie Operating Amends Credit Agreement, Adds Production Covenant, Extends Hudson Bay Warrant Deadline
ProForm 8-KPROP · Form 8-K · 2026-08-17
Profound Medical CFO Rashed Dewan Resigns; Matthew Sobczyk Named Interim CFO
Form 8-KPROF · Form 8-K · 2026-08-17
SOLAI Shareholders Greenlight 1-for-700 Reverse Split and Authorized Capital Surge
ProForm 6-KSLAIY · Form 6-K · 2026-08-17
Adial's Q2 Loss of $52M and Cash Runway into 2H 2027
Form 8-KADIL · Form 8-K · 2026-08-17
TOP Financial Posts Q1 Loss, Cites Unremediated Control Weaknesses
ProForm 10-QTOP · Form 10-Q · 2026-08-17
AmpliTech Provides 2026 Outlook, $17M Backlog, and Tier-1 RFP Update
Form 8-KAMPG · Form 8-K · 2026-08-17
Principal Stockholder to Sell 20.5M Shares; Company to Repurchase $75M Concurrently
Form S-1ALH · Form S-1 · 2026-08-17
Enhertu Hits Primary Endpoint in First-Line HER2-Mutant Lung Cancer
ProForm 6-KAZN · Form 6-K · 2026-08-17
Cloudastructure Reports 164% Subscription Revenue Growth and Regains Nasdaq Compliance
Form 8-KCSAI · Form 8-K · 2026-08-17
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Metastatic NSCLC
ProForm 6-KAZN · Form 6-K · 2026-08-17
InspireMD Q2 Loss Widens to $14.3M; Cash Drops to $30.4M Amid Recall Fallout
Form 8-KNSPR · Form 8-K · 2026-08-17